Clinical investigation
Increased plasma adrenomedullin in acute myocardial infarction

https://doi.org/10.1016/S0002-8703(96)90270-7Get rights and content

Abstract

Adrenomedullin has a potent vasodilating effect comparable to that of calcitonin gene-related peptide. To investigate the pathophysiologic role of endogenous adrenomedullin, we determined sequentially the plasma adrenomedullin level in 15 consecutive patients with acute myocardial infarction (AMI). Plasma adrenomedullin was higher immediately after the onset of AMI and decreased gradually; plasma levels during the 3-week period after the AMI were higher than plasma levels in 15 healthy control subjects (p < 0.001), with higher levels in patients with congestive heart failure than in patients without congestive heart failure throughout the period of the study (p < 0.05). Plasma adrenomedullin was positively correlated with pulmonary capillary wedge pressure, pulmonary arterial pressure, right atrial pressure, and heart rate in the early stage of AMI. These findings suggest that the elevation of plasma adrenomedullin is related to the retention of body fluid volume, the enhancement of sympathetic activity, and/or the elevation of pressure in pulmonary vascular beds. Adrenomedullin may act against excessive vasoconstrictors increased in AMI.

References (27)

  • YC Shekhar et al.

    Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure

    Am J Cardiol

    (1991)
  • T Ebara et al.

    Effect of adrenomedullin on renal hemodynamics and function in dogs

    Eur J Pharmacol

    (1994)
  • K Kitamura et al.

    Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma

    Biochem Biophys Res Commun

    (1993)
  • Cited by (153)

    • Adrenomedullin: Continuing to explore cardioprotection

      2019, Peptides
      Citation Excerpt :

      The AM concentration was determined using specific radioimmunoassay that recognizes human AM-(40–52)-NH2 in humans and rats AM [7,8] or AM-(1–52) in humans [69]. The plasma AM concentration increased in patients with essential hypertension [91,92], heart failure [15,19,69,93–96], and myocardial infarction [97,98], in proportion to the severity of hypertension and heart failure, and intra-cardiac filling pressure. The AM concentration appeared to peak at around 24 h since the admission after acute myocardial infarction onset [97].

    • Bench-to-bedside pharmacology of adrenomedullin

      2015, European Journal of Pharmacology
    View all citing articles on Scopus
    View full text